Samantha McLemore - Patient Capital Management,
Holding/activity history for CVS Health Corp. (CVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,357,159 | 3.63 | Add 10.21% | 0.34 | $71.82 | $97,471,170 | SEC |
| 2025 Q4 | 1,231,416 | 3.77 | Reduce 0.68% | 0.03 | $79.36 | $97,725,148 | SEC |
| 2025 Q3 | 1,239,894 | 3.74 | Reduce 0.16% | <0.01 | $75.39 | $93,475,577 | SEC |
| 2025 Q2 | 1,241,924 | 3.87 | Reduce 6.31% | 0.29 | $68.98 | $85,667,945 | SEC |
| 2025 Q1 | 1,325,638 | 4.62 | Add 2.10% | 0.09 | $67.75 | $89,811,996 | SEC |
| 2024 Q4 | 1,298,429 | 2.69 | Add 68.83% | 1.10 | $44.89 | $58,286,461 | SEC |
| 2024 Q3 | 769,096 | 2.37 | Add 3.97% | 0.09 | $62.88 | $48,360,744 | SEC |
| 2024 Q2 | 739,709 | 2.32 | Add 29.19% | 0.52 | $59.06 | $43,687,207 | SEC |
| 2024 Q1 | 572,574 | 2.22 | Reduce 4.73% | 0.12 | $79.76 | $45,668,474 | SEC |
| 2023 Q4 | 600,977 | 2.52 | Reduce 0.68% | 0.02 | $78.96 | $47,453,109 | SEC |
| 2023 Q3 | 605,120 | 2.49 | Buy | 2.49 | $69.82 | $42,249,505 | SEC |